A New Blood Test to Differentiate Prostate Cancer from BPH Using GASP-1 Protein

Learn about groundbreaking research developing a novel blood test that uses GASP-1 protein levels to distinguish between benign prostatic hyperplasia (BPH) and prostate cancer in this 12-minute scientific presentation. Explore the collaborative work between Halcyon Diagnostics and Rutgers University researchers, featuring advanced tissue analysis techniques including tissue microarray dearraying, color separation, and intensity measurements implemented through Python tools. Discover how GASP-1 expression varies significantly across prostate cancer, BPH, and healthy tissue samples, and understand its potential as a diagnostic marker that could enhance current PSA testing methods while reducing unnecessary biopsies. Gain insights into the technical implementation through the provided GitHub repository and access the complete research findings published in CANCERS journal.